ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression

Nature

Volumn 508, Issue 7495, 2014, Pages 263-268

  Wen, Hong ^a   Li, Yuanyuan ^b,c   Xi, Yuanxin ^d   Jiang, Shiming ^a   Stratton, Sabrina ^a   Peng, Danni ^a   Tanaka, Kaori ^a   Ren, Yongfeng ^b,c   Xia, Zheng ^d   Wu, Jun ^e   Li, Bing ^e   Barton, Michelle C ^a,f   Li, Wei ^d   Li, Haitao ^b,c   Shi, Xiaobing ^a,f  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Tsinghua University   (China)

^c Tsinghua University   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; LYSINE; RNA POLYMERASE II; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZMYND11 PROTEIN; CARRIER PROTEIN; COREPRESSOR PROTEIN; HISTONE; ZMYND11 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENCAPSULATION; FEMALE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION ELONGATION; TUMOR GROWTH; AMINO ACID SEQUENCE; ANIMAL; BREAST TUMOR; CHEMICAL STRUCTURE; CHEMISTRY; CHROMATIN; DISEASE FREE SURVIVAL; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHYLATION; MOLECULAR GENETICS; NUDE MOUSE; ONCOGENE; PATHOLOGY; PROGNOSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

MAMMALIA; MUS;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CARRIER PROTEINS; CHROMATIN; CO-REPRESSOR PROTEINS; CRYSTALLOGRAPHY, X-RAY; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; LYSINE; METHYLATION; MICE; MICE, NUDE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ONCOGENES; PROGNOSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RNA POLYMERASE II; SUBSTRATE SPECIFICITY; TRANSCRIPTION ELONGATION, GENETIC;

EID: 84900312641     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13045     Document Type: Article

References (49)

1. Ruthenburg, A. J., Li, H., Patel, D. J. & Allis, C. D. Multivalent engagement of chromatin modifications by linked binding modules. Nature Rev. Mol. Cell Biol. 8, 983-994 (2007).
2. Venkatesh, S. et al. Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes. Nature 489, 452-455 (2012).
3. Elsaesser, S. J., Goldberg, A. D. & Allis, C. D. New functions for an old variant: no substitute for histone H3.3. Curr. Opin. Genet. Dev. 20, 110-117 (2010).
4. Hateboer, G. et al. BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J. 14, 3159-3169 (1995).
5. Ladendorff, N. E., Wu, S. & Lipsick, J. S. BS69, an adenovirus E1A-associated protein, in hibits the transcriptional activity of c-Myb. Oncogene 20, 125-132 (2001).
6. Wei, G., Schaffner, A. E., Baker, K. M., Mansky, K. C. & Ostrowski, M. C. Ets-2 interacts with co-repressor BS69 to repress target gene expression. Anticancer Res. 23, 2173-2178 (2003).
7. Dhayalan, A. et al. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 285, 26114-26120 (2010).
8. Vezzoli, A. et al. Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nature Struct. Mol. Biol. 17, 617-619 (2010).
9. Wu, H. et al. Structural and histone binding ability characterizations of human PWWP domains. PLoS ONE 6, e18919 (2011).
10. Qiu, C., Sawada, K., Zhang, X. & Cheng, X. The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds. Nature Struct. Biol. 9, 217-224 (2002).
11. Spruijt, C. G. et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152, 1146-1159 (2013).
12. Eidahl, J. O. et al. Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes. Nucleic Acids Res. 41, 3924-3936 (2013).
13. van Nuland, R. et al. Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain. Epigenet. Chromatin 6, 12 (2013).
14. Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134 (1995).
15. Li, Y. & Li, H. Many keys to push: diversifying the 'readership' of plant homeodomain fingers. Acta Biochim. Biophys. Sin. 44, 28-39 (2012).
16. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007).
17. Goldberg, A. D. et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140, 678-691 (2010).
18. Jin, C. et al. H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nature Genet. 41, 941-945 (2009).
19. Ray-Gallet, D. et al. Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol. Cell 44, 928-941 (2011).
20. Edmunds, J. W., Mahadevan, L. C. & Clayton, A. L. Dynamic histone H3methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 27, 406-420 (2008).
21. Kuo, A. J. et al. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol. Cell 44, 609-620 (2011).
22. Rahl, P. B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432-445 (2010).
23. Danko, C. G. et al. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol. Cell 50, 212-222 (2013).
24. Sims, R. J., III, Belotserkovskaya, R. & Reinberg, D. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 18, 2437-2468 (2004).
25. Ansieau, S. & Sergeant, A. BS69 and RACK7, a potential novel class of tumor suppressor genes. Pathol. Biol. (Paris) 51, 397-399 (2003).
26. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231 (2012).
27. Sturm, D. et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22, 425-437 (2012).
28. Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857-861 (2013).
29. Bjerke, L. et al. Histone H3.3 mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov. 3, 512-519 (2013).
30. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
31. Shi, X. et al. ING2PHDdomain links histone H3 lysine 4 methylation to active gene repression. Nature 442, 96-99 (2006).
32. Wen, H. et al. Recognition of histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates histone demethylation. J. Biol. Chem. 285, 9322-9326 (2010).
33. Fish, P. et al. Identification of a chemical probe for BET bromodomain inhibition through optimization of a fragment-derived hit. J. Med. Chem. 55, 9831-9837 (2012).
34. Mendez, J. & Stillman, B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20, 8602-8612 (2000).
35. Li, B. et al. Combined action of PHD and chromo domains directs the Rpd3SHDAC to transcribed chromatin. Science 316, 1050-1054 (2007).
36. Simon, M. D. et al. The site-specific installation of methyl-lysine analogs into recombinant histones. Cell 128, 1003-1012 (2007).
37. Zeitlinger, J. et al. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nature Genet. 39, 1512-1516 (2007).
38. Boettiger, A. N. & Levine, M. Synchronous and stochastic patterns of gene activation in the Drosophila embryo. Science 325, 471-473 (2009).
39. Nechaev, S. & Adelman, K. Promoter-proximal Pol II: when stalling speeds things up. Cell Cycle 7, 1539-1544 (2008).
40. Naar, A. M., Lemon, B. D. & Tjian, R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70, 475-501 (2001).
41. Luo, Z., Lin, C. & Shilatifard, A. The super elongation complex (SEC) family in transcriptional control. Nature Rev. Mol. Cell Biol. 13, 543-547 (2012).
42. Turnbull, W. B. & Daranas, A. H. On the value of c: can low affinity systems be studied by isothermal titration calorimetry? J. Am. Chem. Soc. 125, 14859-14866 (2003).
43. Lowary, P. T. & Widom, J. New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning. J. Mol. Biol. 276, 19-42 (1998).
44. Abmayr, S. M., Yao, T., Parmely, T. & Workman, J. L. Preparation of nuclear and cytoplasmic extracts from mammalian cells. Curr. Protoc. Mol. Biol. 12.11, (2006).
45. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
46. Eswaran, J. et al. Structure and functional characterization of the atypical human kinase haspin. Proc. Natl Acad. Sci. USA 106, 20198-20203 (2009).
47. Akue-Gedu, R. et al. Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors. J. Med. Chem. 52, 6369-6381 (2009).
48. Barr, A. J. et al. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136, 352-363 (2009).
49. Kessler, J. D. et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348-353 (2012).